BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17851869)

  • 1. Techniques of tumour bed boost irradiation in breast conserving therapy: current evidence and suggested guidelines.
    Jalali R; Singh S; Budrukkar A
    Acta Oncol; 2007; 46(7):879-92. PubMed ID: 17851869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
    Sautter-Bihl ML; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sedlmayer F; Souchon R; Wenz F; Sauer R; ;
    Strahlenther Onkol; 2007 Dec; 183(12):661-6. PubMed ID: 18040609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
    Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
    Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
    Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
    Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
    Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
    Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor bed boost omission after negative re-excision in breast-conservation treatment.
    Arthur DW; Cuttino LW; Neuschatz AC; Koo DT; Morris MM; Bear HD; Kaplan BJ; Dawson K; Wazer DE
    Ann Surg Oncol; 2006 Jun; 13(6):794-801. PubMed ID: 16614879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation treatment for ductal carcinoma in situ (DCIS): is a boost to the tumor bed necessary?
    Yerushalmi R; Sulkes A; Mishaeli M; Neumann A; Dinerman M; Sulkes J; Rizel S; Yarom N; Gutman H; Fenig E
    Neoplasma; 2006; 53(6):507-10. PubMed ID: 17167720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cosmesis, late sequelae and local control after breast-conserving therapy: influence of type of tumour bed boost and adjuvant chemotherapy.
    Budrukkar AN; Sarin R; Shrivastava SK; Deshpande DD; Dinshaw KA
    Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):596-603. PubMed ID: 17706403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
    Poortmans P; Bartelink H; Horiot JC; Struikmans H; Van den Bogaert W; Fourquet A; Jager J; Hoogenraad W; Rodrigus P; Wárlám-Rodenhuis C; Collette L; Pierart M;
    Radiother Oncol; 2004 Jul; 72(1):25-33. PubMed ID: 15236871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for local recurrence in patients with limited surgery and irradiation of breast cancer.
    Stadler B; Staffen A; Strasser K; Wrba F; Stanek C
    Strahlenther Onkol; 1990 Jul; 166(7):453-6. PubMed ID: 2166352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.
    Antonini N; Jones H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Jager J; Hoogenraad W; Collette L; Pierart M; Hart G; Bartelink H
    Radiother Oncol; 2007 Mar; 82(3):265-71. PubMed ID: 17126434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
    Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
    Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
    Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
    Freedman GM; Anderson PR; Goldstein LJ; Ma CM; Li J; Swaby RF; Litwin S; Watkins-Bruner D; Sigurdson ER; Morrow M
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):347-53. PubMed ID: 17379430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted intraoperative radiotherapy (TARGIT) yields very low recurrence rates when given as a boost.
    Vaidya JS; Baum M; Tobias JS; Massarut S; Wenz F; Murphy O; Hilaris B; Houghton J; Saunders C; Corica T; Roncadin M; Kraus-Tiefenbacher U; Melchaert F; Keshtgar M; Sainsbury R; Douek M; Harrison E; Thompson A; Joseph D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1335-8. PubMed ID: 17084562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
    Buchholz TA; Haffty BG; Harris JR
    J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
    [No Abstract]   [Full Text] [Related]  

  • 19. [Partial breast irradiation: high dose rate peroperative brachytherapy technique using the MammoSite].
    Belkacémi Y; Chauvet MP; Giard S; Poupon L; Castellanos ME; Villette S; Bonodeau F; Cabaret V; Lartigau E
    Cancer Radiother; 2003 Nov; 7 Suppl 1():129s-136s. PubMed ID: 15124555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The future of breast cancer radiotherapy: From one size fits all to taylor-made treatment].
    Hennequin C; Azria D
    Cancer Radiother; 2011 Oct; 15(6-7):455-9. PubMed ID: 21820932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.